Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Byrne

Showing results (181-190 of 1,004) with videos related to

Pageof 101
Sort By:
Journal of Clinical Pathology|December 29, 2000
Fetal origins of adult disease: epidemiology and mechanismsC D Byrne, D I Phillips
Evidence-Based Medicine|February 1, 2008
Review: thiazolidinediones increase risk of heart failure in type 2 diabetesChristopher D Byrne, Sarah H Wild
Irish Medical Journal|March 25, 2014
Imaging findings in emphysematous gastritisD Byrne, M Arrigan, N Ravi
Archives of Microbiology|October 1, 1982
A reappraisal of antigenic determinants for nitrogenase from Azotobacter and nitrate reductase from Escherichia coliM D Byrne, D J Nicholas
Diabetes, Obesity & Metabolism|June 20, 2008
Current treatment of non-alcoholic fatty liver diseaseMohamed H Ahmed, Christopher D Byrne
Nutrition Research Reviews|December 17, 2008
Evidence for fetal programming of obesity with a focus on putative mechanismsSarah H Wild, Christopher D Byrne
Fetal Diagnosis and Therapy|January 1, 1991
Why cell culture is successful after early amniocentesisD Byrne, G Azar, K Nicolaides
Journal of Shoulder and Elbow Surgery|January 24, 2007
Adhesive capsulitis: human fibroblast response to shoulder joint aspirate from patients with stage II diseaseH Mullett, D Byrne, J Colville
Drug Discovery Today|September 11, 2007
Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD)Mohamed H Ahmed, Christopher D Byrne
BMJ (Clinical Research Ed.)|August 10, 2011
Increased risk of glucose intolerance and type 2 diabetes with statinsChristopher D Byrne, Sarah H Wild
Pageof 101

Showing results (181-190 of 1,004) with videos related to

Sort By:
Pageof 101
Journal of Clinical Pathology|December 29, 2000
Fetal origins of adult disease: epidemiology and mechanismsC D Byrne, D I Phillips
Evidence-Based Medicine|February 1, 2008
Review: thiazolidinediones increase risk of heart failure in type 2 diabetesChristopher D Byrne, Sarah H Wild
Irish Medical Journal|March 25, 2014
Imaging findings in emphysematous gastritisD Byrne, M Arrigan, N Ravi
Archives of Microbiology|October 1, 1982
A reappraisal of antigenic determinants for nitrogenase from Azotobacter and nitrate reductase from Escherichia coliM D Byrne, D J Nicholas
Diabetes, Obesity & Metabolism|June 20, 2008
Current treatment of non-alcoholic fatty liver diseaseMohamed H Ahmed, Christopher D Byrne
Nutrition Research Reviews|December 17, 2008
Evidence for fetal programming of obesity with a focus on putative mechanismsSarah H Wild, Christopher D Byrne
Fetal Diagnosis and Therapy|January 1, 1991
Why cell culture is successful after early amniocentesisD Byrne, G Azar, K Nicolaides
Journal of Shoulder and Elbow Surgery|January 24, 2007
Adhesive capsulitis: human fibroblast response to shoulder joint aspirate from patients with stage II diseaseH Mullett, D Byrne, J Colville
Drug Discovery Today|September 11, 2007
Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD)Mohamed H Ahmed, Christopher D Byrne
BMJ (Clinical Research Ed.)|August 10, 2011
Increased risk of glucose intolerance and type 2 diabetes with statinsChristopher D Byrne, Sarah H Wild
Pageof 101